philip j. barter, et al. circulation 2011;124:555-562
DESCRIPTION
Philip J. Barter, et al. Circulation 2011;124:555-562. Baseline Characteristics of Randomized Subjects With Diabetes Mellitus – Part I. Philip J. Barter, et al. Circulation 2011;124:555-562. Baseline Characteristics of Randomized Subjects With Diabetes Mellitus – Part II. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Philip J. Barter, et al. Circulation 2011;124:555-562](https://reader036.vdocuments.us/reader036/viewer/2022062722/568139c0550346895da16667/html5/thumbnails/1.jpg)
Philip J. Barter, et al. Circulation 2011;124:555-562
![Page 2: Philip J. Barter, et al. Circulation 2011;124:555-562](https://reader036.vdocuments.us/reader036/viewer/2022062722/568139c0550346895da16667/html5/thumbnails/2.jpg)
Baseline Characteristics of Randomized Subjects With Diabetes Mellitus – Part I
Philip J. Barter, et al. Circulation 2011;124:555-562
![Page 3: Philip J. Barter, et al. Circulation 2011;124:555-562](https://reader036.vdocuments.us/reader036/viewer/2022062722/568139c0550346895da16667/html5/thumbnails/3.jpg)
Baseline Characteristics of Randomized Subjects With Diabetes Mellitus – Part II
Philip J. Barter, et al. Circulation 2011;124:555-562
![Page 4: Philip J. Barter, et al. Circulation 2011;124:555-562](https://reader036.vdocuments.us/reader036/viewer/2022062722/568139c0550346895da16667/html5/thumbnails/4.jpg)
Effects of Treatment With Atorvastatin vs the Combination of Atorvastatin and Torcetrapib on Plasma Glucose, Hemoglobin A1c, Serum Insulin,
HOMA-IR, and HDL Cholesterol for the Subgroup of Diabetic Subjects
Philip J. Barter, et al. Circulation 2011;124:555-562
![Page 5: Philip J. Barter, et al. Circulation 2011;124:555-562](https://reader036.vdocuments.us/reader036/viewer/2022062722/568139c0550346895da16667/html5/thumbnails/5.jpg)
Between-Treatment Comparison of Changes in Glucose, Insulin, Hemoglobin A1c, and HOMA-IR Adjusted for Change in HDL Cholesterol - I
Philip J. Barter, et al. Circulation 2011;124:555-562
![Page 6: Philip J. Barter, et al. Circulation 2011;124:555-562](https://reader036.vdocuments.us/reader036/viewer/2022062722/568139c0550346895da16667/html5/thumbnails/6.jpg)
Philip J. Barter, et al. Circulation 2011;124:555-562
Between-Treatment Comparison of Changes in Glucose, Insulin, Hemoglobin A1c, and HOMA-IR Adjusted for Change in HDL Cholesterol - II
![Page 7: Philip J. Barter, et al. Circulation 2011;124:555-562](https://reader036.vdocuments.us/reader036/viewer/2022062722/568139c0550346895da16667/html5/thumbnails/7.jpg)
Effects of Treatment With Atorvastatin vs the Combination of Atorvastatin and Torcetrapib on Plasma Glucose, Hemoglobin A1c, Serum Insulin,
HOMA-IR, and HDL Cholesterol for the Subgroup of Nondiabetic Subjects
Philip J. Barter, et al. Circulation 2011;124:555-562
![Page 8: Philip J. Barter, et al. Circulation 2011;124:555-562](https://reader036.vdocuments.us/reader036/viewer/2022062722/568139c0550346895da16667/html5/thumbnails/8.jpg)
CLINICAL PERSPECTIVE
Philip J. Barter, et al. Circulation 2011;124:555-562